A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.

Saved in:
Bibliographic Details
Title: A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Authors: Uronis, Hope1, Jia, Jingquan, Bendell, Johanna2, Howard, Leigh1, Ready, Neal1, Lee, Paula1, Starr, Mark1, Dellinger, Andrew, Pang, Herbert, Nixon, Andrew1, Hurwitz, Herbert1 hurwi004@mc.duke.edu
Source: Cancer Chemotherapy & Pharmacology. Feb2015, Vol. 75 Issue 2, p343-352. 10p.
Database: Academic Search Ultimate
Description
ISSN:03445704
DOI:10.1007/s00280-014-2647-x